Delivery Order SPE2DB22D3301-SPE2DB24FY1MH
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,240.98 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of $8,558.34 worth of ABRAXANE 100 mg vials. The contract has a period of performance through January 31, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, a delivery order valued at $2,727.68, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a firm fixed price pricing structure and an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of ABRAXANE 100 MG VIALS, a pharmaceutical product, with a ceiling value of $4,833.48 and a completion date of April 30, 2024. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,288.39 firm fixed price contract is for the supply of ABRAXANE 100 MG vials, a specialty oncology medication. The award has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRAXANE 100 MG VIALS. The contract has a ceiling value of $35,702.00 and runs through September 28, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
- The Defense Logistics Agency awarded a delivery order valued at $16,261.46 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with an ultimate completion date of November 21, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,122.92 firm fixed price delivery order is for 100 mg vials of the cancer drug Abraxane. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $20,776.50 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. This award does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract (IDC) previously awarded...
- This federal contract award (SPE2DB22D3016|SPE2DB24FAQG5) was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4564002820 ABRAXANE 100 MG VIALS. The contract is a firm fixed price delivery order with a ceiling value of $2,246.82 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also received a separate...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY1MHDelivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the provision of ABRAXANE 100 MG VIALS. The contract has a potential value of $8,837.51 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 2/27/24 |